Literature DB >> 1548955

The next 5 years in cardiac pacemakers: a preview.

D L Hayes1.   

Abstract

Advances in cardiac pacing continue at an astounding rate, and, occasionally, technologic capabilities are developed almost faster than they can be implemented clinically. The development and implementation of single- and dual-chamber rate-adaptive pacemakers have been the major thrusts in cardiac pacing in recent years. Rate-adaptive pacing will continue to be of primary interest in the future as investigators search for the perfect "sensor" and attempt to develop rate-adaptive pacemakers with multiple sensors. The "smart" pacemaker--that is, an autoprogramming, autodiagnostic device--will also be refined. The ultimate "smart" pacemaker would be capable of automatically adjusting output and sensing factors as well as altering the rate-adaptive variables and even changing the pacing mode in response to variations in the underlying rhythm. Other aspects of cardiac pacing that will be actively investigated include new low-threshold pacing lead designs, refinements of the single-lead pacing system capable of P-synchronous pacing, and diagnostic information that can be derived from sensors used for rate-adaptive pacing.

Entities:  

Mesh:

Year:  1992        PMID: 1548955     DOI: 10.1016/s0025-6196(12)61556-0

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  2 in total

Review 1.  Cardiac pacing: the service should be as local as the anaesthetic.

Authors:  D Pitcher
Journal:  Br Heart J       Date:  1995-07

2.  Systematic Investigation of Polyurethane Biomaterial Surface Roughness on Human Immune Responses in vitro.

Authors:  Sören Segan; Meike Jakobi; Paree Khokhani; Sascha Klimosch; Florian Billing; Markus Schneider; Dagmar Martin; Ute Metzger; Antje Biesemeier; Xin Xiong; Ashutosh Mukherjee; Heiko Steuer; Bettina-Maria Keller; Thomas Joos; Manfred Schmolz; Ulrich Rothbauer; Hanna Hartmann; Claus Burkhardt; Günter Lorenz; Nicole Schneiderhan-Marra; Christopher Shipp
Journal:  Biomed Res Int       Date:  2020-05-11       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.